SE Davis, L Zabotka, RJ Desai, SV Wang, JC Maro… - Drug Safety, 2023 - Springer
Introduction Pharmacovigilance programs protect patient health and safety by identifying adverse event signals through postmarketing surveillance of claims data and spontaneous …
X Wang, L Li, L Wang, W Feng, P Zhang - Statistics in Medicine, 2020 - Wiley Online Library
With increasing trend of polypharmacy, drug‐drug interaction (DDI)‐induced adverse drug events (ADEs) are considered as a major challenge for clinical practice. As premarketing …
WH Chiang, L Shen, L Li… - International Journal of …, 2020 - inderscienceonline.com
High-order drug-drug interactions (DDIs) and associated adverse drug reactions (ADRs) are common, particularly for elderly people, and therefore represent a significant public health …
B Peng, X Ning - Proceedings of the 10th ACM international conference …, 2019 - dl.acm.org
Drug-drug interactions (DDIs) and their associated adverse drug reactions (ADRs) represent a significant detriment to the public health. Existing research on DDIs is primarily focused on …
Introduction Polypharmacy is common and is associated with higher risk of adverse drug event (ADE) among older adults. Knowledge on the ADE risk level of exposure to different …
Case‐control design based high‐throughput pharmacoinformatics study using large‐scale longitudinal health data is able to detect new adverse drug event (ADEs) signals. Existing …
Pharmacoinformatics research has experienced a great deal of successes in detecting drug‐ induced adverse events (AEs) using large‐scale health record databases. In the era of …
Drug-drug interactions (DDIs) and associated adverse drug reactions (ADRs) represent a significant public health problem in the USA. The research presented in this manuscript …
D Aleksić - Универзитет у Крагујевцу, 2020 - nardus.mpn.gov.rs
САЖЕТАК Увод: Клинички релевантне потенцијалне интеракције лекова (ПИЛ) сматрају се нежељеним реакцијама на лек које се могу спречити. Циљ ове дисертације …